259 related articles for article (PubMed ID: 23204307)
1. Endocytic mechanism of transferrin-conjugated nanoparticles and the effects of their size and ligand number on the efficiency of drug delivery.
Tsuji T; Yoshitomi H; Usukura J
Microscopy (Oxf); 2013 Jun; 62(3):341-52. PubMed ID: 23204307
[TBL] [Abstract][Full Text] [Related]
2. Anti-tumor activity of paclitaxel through dual-targeting carrier of cyclic RGD and transferrin conjugated hyperbranched copolymer nanoparticles.
Xu Q; Liu Y; Su S; Li W; Chen C; Wu Y
Biomaterials; 2012 Feb; 33(5):1627-39. PubMed ID: 22118775
[TBL] [Abstract][Full Text] [Related]
3. Targeted delivery of doxorubicin using stealth liposomes modified with transferrin.
Li X; Ding L; Xu Y; Wang Y; Ping Q
Int J Pharm; 2009 May; 373(1-2):116-23. PubMed ID: 19429296
[TBL] [Abstract][Full Text] [Related]
4. Brain delivery and cellular internalization mechanisms for transferrin conjugated biodegradable polymersomes.
Pang Z; Gao H; Yu Y; Chen J; Guo L; Ren J; Wen Z; Su J; Jiang X
Int J Pharm; 2011 Aug; 415(1-2):284-92. PubMed ID: 21651966
[TBL] [Abstract][Full Text] [Related]
5. Clathrin and caveolin-1 expression in primary pigmented rabbit conjunctival epithelial cells: role in PLGA nanoparticle endocytosis.
Qaddoumi MG; Gukasyan HJ; Davda J; Labhasetwar V; Kim KJ; Lee VH
Mol Vis; 2003 Oct; 9():559-68. PubMed ID: 14566223
[TBL] [Abstract][Full Text] [Related]
6. Enhanced intracellular delivery and chemotherapy for glioma rats by transferrin-conjugated biodegradable polymersomes loaded with doxorubicin.
Pang Z; Gao H; Yu Y; Guo L; Chen J; Pan S; Ren J; Wen Z; Jiang X
Bioconjug Chem; 2011 Jun; 22(6):1171-80. PubMed ID: 21528923
[TBL] [Abstract][Full Text] [Related]
7. Selective cellular uptake and induction of apoptosis of cancer-targeted selenium nanoparticles.
Huang Y; He L; Liu W; Fan C; Zheng W; Wong YS; Chen T
Biomaterials; 2013 Sep; 34(29):7106-16. PubMed ID: 23800743
[TBL] [Abstract][Full Text] [Related]
8. Size-dependent internalisation of folate-decorated nanoparticles via the pathways of clathrin and caveolae-mediated endocytosis in ARPE-19 cells.
Langston Suen WL; Chau Y
J Pharm Pharmacol; 2014 Apr; 66(4):564-73. PubMed ID: 24635558
[TBL] [Abstract][Full Text] [Related]
9. Improving the systemic drug delivery efficacy of nanoparticles using a transferrin variant for targeting.
Chiu RY; Tsuji T; Wang SJ; Wang J; Liu CT; Kamei DT
J Control Release; 2014 Apr; 180():33-41. PubMed ID: 24524898
[TBL] [Abstract][Full Text] [Related]
10. Synergistic anti-cancer effects via co-delivery of TNF-related apoptosis-inducing ligand (TRAIL/Apo2L) and doxorubicin using micellar nanoparticles.
Lee AL; Dhillon SH; Wang Y; Pervaiz S; Fan W; Yang YY
Mol Biosyst; 2011 May; 7(5):1512-22. PubMed ID: 21350763
[TBL] [Abstract][Full Text] [Related]
11. Tumor-targeted and pH-controlled delivery of doxorubicin using gold nanorods for lung cancer therapy.
Amreddy N; Muralidharan R; Babu A; Mehta M; Johnson EV; Zhao YD; Munshi A; Ramesh R
Int J Nanomedicine; 2015; 10():6773-88. PubMed ID: 26604751
[TBL] [Abstract][Full Text] [Related]
12. Transferrin-conjugated lipid-coated PLGA nanoparticles for targeted delivery of aromatase inhibitor 7alpha-APTADD to breast cancer cells.
Zheng Y; Yu B; Weecharangsan W; Piao L; Darby M; Mao Y; Koynova R; Yang X; Li H; Xu S; Lee LJ; Sugimoto Y; Brueggemeier RW; Lee RJ
Int J Pharm; 2010 May; 390(2):234-41. PubMed ID: 20156537
[TBL] [Abstract][Full Text] [Related]
13. Tumor-targeting transferrin nanoparticles for systemic polymerized siRNA delivery in tumor-bearing mice.
Yhee JY; Lee SJ; Lee S; Song S; Min HS; Kang SW; Son S; Jeong SY; Kwon IC; Kim SH; Kim K
Bioconjug Chem; 2013 Nov; 24(11):1850-60. PubMed ID: 24107100
[TBL] [Abstract][Full Text] [Related]
14. Characterization of endocytosis of transferrin-coated PLGA nanoparticles by the blood-brain barrier.
Chang J; Jallouli Y; Kroubi M; Yuan XB; Feng W; Kang CS; Pu PY; Betbeder D
Int J Pharm; 2009 Sep; 379(2):285-92. PubMed ID: 19416749
[TBL] [Abstract][Full Text] [Related]
15. Coated endosomal vesicles: sorting and recycling compartment for transferrin in BHK cells.
Eskelinen S; Kok JW; Sormunen R; Hoekstra D
Eur J Cell Biol; 1991 Dec; 56(2):210-22. PubMed ID: 1802708
[TBL] [Abstract][Full Text] [Related]
16. Effect of transferrin receptor-targeted liposomal doxorubicin in P-glycoprotein-mediated drug resistant tumor cells.
Kobayashi T; Ishida T; Okada Y; Ise S; Harashima H; Kiwada H
Int J Pharm; 2007 Feb; 329(1-2):94-102. PubMed ID: 16997518
[TBL] [Abstract][Full Text] [Related]
17. Transferrin adsorption onto PLGA nanoparticles governs their interaction with biological systems from blood circulation to brain cancer cells.
Chang J; Paillard A; Passirani C; Morille M; Benoit JP; Betbeder D; Garcion E
Pharm Res; 2012 Jun; 29(6):1495-505. PubMed ID: 22167349
[TBL] [Abstract][Full Text] [Related]
18. Transferrin surface-modified PLGA nanoparticles-mediated delivery of a proteasome inhibitor to human pancreatic cancer cells.
Frasco MF; Almeida GM; Santos-Silva F; Pereira Mdo C; Coelho MA
J Biomed Mater Res A; 2015 Apr; 103(4):1476-84. PubMed ID: 25046528
[TBL] [Abstract][Full Text] [Related]
19. Transferrin-conjugated nanodiamond as an intracellular transporter of chemotherapeutic drug and targeting therapy for cancer cells.
Wang D; Li Y; Tian Z; Cao R; Yang B
Ther Deliv; 2014 May; 5(5):511-24. PubMed ID: 24998271
[TBL] [Abstract][Full Text] [Related]
20. A transferrin variant as the targeting ligand for polymeric nanoparticles incorporated in 3-D PLGA porous scaffolds.
Lopes AM; Chen KY; Kamei DT
Mater Sci Eng C Mater Biol Appl; 2017 Apr; 73():373-380. PubMed ID: 28183621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
